These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23328996)

  • 1. A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery.
    Pu J; Qin SS; Ding JX; Zhang Y; Zhu WG; Yu CH; Li T; Tao GZ; Ji FZ; Zhou XL; Han JH; Ji YL; Sun JX
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):703-8. PubMed ID: 23328996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
    Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
    Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
    Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
    Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: A phase II trial.
    Wang X; Shen Y; Zhao Y; Li Z; Gou H; Cao D; Yang Y; Qiu M; Li Q; Liu J; Yi C; Liao Z; Luo D; Xu F; Bi F
    Eur J Surg Oncol; 2015 Aug; 41(8):1082-8. PubMed ID: 26033265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of induction chemotherapy with vinorelbine plus cisplatin (NP) or docetaxel plus cisplatin (TP) combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma].
    Han SH; Yu L; Zhang Z; Zhang PJ; Song HP; Guo CY
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):623-6. PubMed ID: 24314223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
    Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
    Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
    Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
    Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
    Bradbury M; Founta C; Taylor W; Kucukmetin A; Naik R; Ang C
    Int J Gynecol Cancer; 2015 Oct; 25(8):1476-83. PubMed ID: 26244756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy.
    Hosaka M; Watari H; Kato T; Odagiri T; Konno Y; Endo D; Mitamura T; Kikawa S; Suzuki Y; Sakuragi N
    J Surg Oncol; 2012 May; 105(6):612-6. PubMed ID: 22065519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early stage cervical cancer with negative pelvic lymph nodes: pattern of failure and complication following radical hysterectomy and adjuvant radiotherapy.
    Chen SW; Liang JA; Yang SN; Lin FJ
    Eur J Gynaecol Oncol; 2004; 25(1):81-6. PubMed ID: 15053068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of postoperative simple chemotherapy and concurrent chemoradiotherapy in FIGO stage IB2-IIB cervical cancer].
    Ma K; Yang YH; Yang X; Feng ZY; Liu TY; Wen HW; Liao QP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):910-5. PubMed ID: 24343073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.
    Peters WA; Liu PY; Barrett RJ; Stock RJ; Monk BJ; Berek JS; Souhami L; Grigsby P; Gordon W; Alberts DS
    J Clin Oncol; 2000 Apr; 18(8):1606-13. PubMed ID: 10764420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Induction chemotherapy with docetaxel plus cisplatin (TP regimen) followed by concurrent chemoradiotherapy with TP regimen versus cisplatin in treating locally advanced nasopharyngeal carcinoma].
    Xie FY; Zou GR; Hu WH; Qi SN; Peng M; Li JS
    Ai Zheng; 2009 Mar; 28(3):279-85. PubMed ID: 19619443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial.
    Shrivastava S; Mahantshetty U; Engineer R; Chopra S; Hawaldar R; Hande V; Kerkar RA; Maheshwari A; Shylasree TS; Ghosh J; Bajpai J; Gurram L; Gulia S; Gupta S;
    JAMA Oncol; 2018 Apr; 4(4):506-513. PubMed ID: 29423520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective review of patients with stage IB2 cervical cancer treated with radical radiation versus radical surgery as a primary modality.
    Alleyne-Mike K; van Wijk L; Hunter A
    Int J Gynecol Cancer; 2013 Sep; 23(7):1287-94. PubMed ID: 23863456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.
    Gupta S; Maheshwari A; Parab P; Mahantshetty U; Hawaldar R; Sastri Chopra S; Kerkar R; Engineer R; Tongaonkar H; Ghosh J; Gulia S; Kumar N; Shylasree TS; Gawade R; Kembhavi Y; Gaikar M; Menon S; Thakur M; Shrivastava S; Badwe R
    J Clin Oncol; 2018 Jun; 36(16):1548-1555. PubMed ID: 29432076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the survival outcome of neoadjuvant therapy followed by radical surgery with that of concomitant chemoradiotherapy in patients with stage IB2-IIIB cervical adenocarcinoma.
    Tian T; Gao X; Ju Y; Ding X; Ai Y
    Arch Gynecol Obstet; 2021 Mar; 303(3):793-801. PubMed ID: 33009996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early efficacy of taxotere and cisplatin chemo-radiotherapy for advanced cervical cancer.
    Ke QH; Zhou SQ; Du W; Lei Y; Huang M; Luo F; Yang JY
    Asian Pac J Cancer Prev; 2012; 13(2):617-9. PubMed ID: 22524834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.